New Year, New You
The start of the year is a great time to clear the decks mentally and review for yourself what works and what does not....
This website uses cookies. to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking “Accept & Close”, you consent to our use of cookies. Read our Privacy Policy to learn more.
By: William Prentice
Published: 7/18/2019
Ambulatory surgery center payment rates as a percentage of the hospital outpatient department rates have steadily declined over the years. In 2003, procedures performed in an ASC setting cost Medicare 85% of the amount paid to HOPDs. That figure dropped to 55% in 2014 and today stands at 50%. It's important to note that ASC payments have not declined during this time. What has declined is, on average, the percentage of HOPD payments the ASC payments represent.
The No. 1 reason for the widening cost differentials? CMS uses separate inflationary measures to determine reimbursement rates for HOPDs and ASCs. For years, the Ambulatory Surgery Center Association (ASCA) has been asking Congress and CMS to update ASCs using the same inflation factors they used for HOPDs. And that finally happened this year — one of several recent successes in our efforts to level the reimbursement playing field between ASCs and hospitals.
1Same inflationary measures
Historically, CMS used an economic measure known as Consumer Price Index for All Urban Consumers (CPI-U) to update ASCs for inflation each year, but updated HOPDs using a different measure, the Hospital Market Basket. The differences between CPI-U and Hospital Market Basket are profound.
As a result, most years — because medical inflation outpaces overall inflation — the gap between the inflationary rate that the hospitals received and what the ASCs got was getting larger and larger.
Besides ASCs falling further and further behind HOPDs, the fallout included hospitals buying the ASC down the street and flipping it into a hospital outpatient department so they could get the higher reimbursement rate. CMS has finally agreed to update ASCs using the same inflation factor. For the next 5 years, CMS will update ASCs using the Hospital Market Basket. As a result of that, ASCs this year received their largest inflationary increase — 2.1% — over the past decade.
Getting ASCs off the CPI-U is a great first step in terms of trying to decrease the payment disparities between surgery centers and other settings.
2Separate medical device payment
We also made some progress in Medicare's device-intensive threshold policy, which dictates when an ASC can be reimbursed for the cost of a medical device.
Previously, the cost of the device had to be 50% or more of the total cost of the procedure in the hospital outpatient setting in order for the ASC to get paid separately for the device. That was a huge burden.
For example, if the cost of the device used in a knee arthroscopy was 45% of the cost of the total procedure in the HOPD space, ASCs would not get reimbursed for the full cost of the device. That was a big disincentive to performing those procedures in an ASC. The ASC literally could not afford to do that procedure because the device cost ate up nearly the entire reimbursement of the procedure.
ASCA went to CMS a few years ago and asked them to address this. They agreed to move the device-intensive threshold down to 40%, and ASCs were able to do some device-intensive procedures for the first time.
This year, we got that threshold down to 30%, which opens up probably 100 or more different procedures that were previously cost-prohibitive. That means some of those device-intensive procedures that were stuck in the HOPD space because ASCs couldn't afford to provide them are now going to be able to migrate to ASCs.
The knee arthroscopy code CPT 29888 was impacted by this policy change. In 2018, the national reimbursement rate was approximately $2,700. Since Medicare estimates the device cost at almost $2,000, that left only $700 to pay for everything else the facility is supposed to cover (nursing, other staff, equipment, supplies, operating room use). In 2019, Medicare reimburses ASCs $3,700 for this code, providing more adequate reimbursement to cover all the costs that are covered under the facility fee.
Medicare is taking the approach to reduce the threshold gradually and seeing what moves. I think the volume of procedures that move will dictate what Medicare does going forward with this policy.
3Non-opioid pain therapies
The Trump administration has made dealing with the opioid crisis a priority. ASCA pointed out to the administration that, in terms of Medicare policy, CMS wouldn't
reimburse ASCs for using some non-opioid pain therapies. They agreed to pay ASCs separately for using some non-opioid pain relief during a procedure that would reduce the likelihood of having to prescribe opioids after the procedure. Right
now, this only applies to one drug — the local anesthetic Exparel (liposomal bupivacaine) — but there are other non-opioid approaches, like pain pumps and other modalities, that have the same positive impact on reducing pain without
the use of opioids, for which CMS should also separately reimburse. OSM
The start of the year is a great time to clear the decks mentally and review for yourself what works and what does not....
It’s Saturday, December 28. Have you taken much (or any) time off this year? Make sure you do — not just for your own benefit, but also to set an example for your...
The holiday season can throw some employees off track, draining their levels of engagement and enthusiasm for their jobs at the end of a long year....